Literature DB >> 7909306

Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions.

L M Demeter1, M H Stoler, T R Broker, L T Chow.   

Abstract

The expression of proliferating cell nuclear antigen (PCNA) was studied in human papillomavirus (HPV)-infected, benign and malignant lesions of the genital tract and larynx using immunocytochemical staining of formalin-fixed clinical specimens. We observed the induction of PCNA in squamous carcinomas and adenocarcinomas, as has been demonstrated with other malignancies. In addition, the differentiated keratinocytes of the upper spinous cells and granulocytes in condylomata acuminata and low-grade intraepithelial neoplasias showed a consistent induction of PCNA compared with the normal squamous epithelium, in which only some of the parabasal and basal cells were positive. This reactivation of PCNA synthesis correlated with the presence of high copy numbers of HPV DNA and was independent of the oncogenic risk potential of the infecting HPV genotype. We postulate that HPV gene products induce the expression of PCNA and other components of the host DNA replication machinery in differentiated cells of squamous lesions to facilitate vegetative viral replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909306     DOI: 10.1016/0046-8177(94)90141-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle.

Authors:  E R Flores; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Proliferation in the normal cervix and in preinvasive cervical lesions.

Authors:  S Payne; N M Kernohan; F Walker
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Post-transcriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities.

Authors:  D C Schmidt-Grimminger; X Wu; Y Jian; T R Broker; L T Chow
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes.

Authors:  R D Steenbergen; J N Parker; S Isern; P J Snijders; J M Walboomers; C J Meijer; T R Broker; L T Chow
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Using biomarkers as objective standards in the diagnosis of cervical biopsies.

Authors:  Mary T Galgano; Philip E Castle; Kristen A Atkins; William K Brix; Sarah R Nassau; Mark H Stoler
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

8.  Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.

Authors:  L M Coussens; D Hanahan; J M Arbeit
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

9.  Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers.

Authors:  Kate Middleton; Woei Peh; Shirley Southern; Heather Griffin; Karl Sotlar; Tomomi Nakahara; Amira El-Sherif; Lesley Morris; Rashmi Seth; Merilyn Hibma; David Jenkins; Paul Lambert; Nicholas Coleman; John Doorbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.

Authors:  S Hietanen; K Syrjänen; S Syrjänen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.